Claris Bio

Claris Bio announced a headquarters milestone on September 24, 2026. Claris Bio will relocate its corporate headquarters from Jersey City to South San Francisco in October 2026 as it advances CSB-001.

What changed

The announcement changes the company’s headquarters footprint from Jersey City, NJ to South San Francisco, CA. The relocation becomes effective in October 2026 and places the company in the Bay Area while it advances CSB-001 toward pivotal studies and expands commercial, clinical-development, and finance hiring.

• New headquarters: 701 Gateway Boulevard, Suite 250, South San Francisco, CA
• Previous headquarters: Jersey City, NJ
• Announcement date: September 24, 2026

Why the company chose this location

Claris Bio cited proximity to biotechnology talent, scientific collaborators, and life-sciences capital as it prepares for the next stage of clinical and commercial growth.

What the move signals

A headquarters opening or relocation can signal new hiring capacity, consolidation of operating teams, investment in a regional ecosystem, or a change in how a company serves customers and partners. For GTM teams, the useful next step is to watch for role openings, regional leadership appointments, vendor consolidation, and facilities-related initiatives connected to the move.

Source and methodology

This profile uses the company or property owner’s announcement as its primary source. Future opening dates and planned occupancy are presented as announced and may change.

Primary source: Claris Bio company announcement.